- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02045082
The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
February 25, 2016 updated by: CHU de Quebec-Universite Laval
Comparison Between the Sensibility of the Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
The purpose of this study is to compare a corneal sampling realized by a flocked swab (flocked swab regular 519CS01) with a sampling by traditional fiber swab (Copan regular swab 164KS01 in polyester).
Their impact on the sensibility of the viral culture in the Herpes simplex epithelial keratitis will be the primary objective of this study.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
In our center, the flocked swabs became an important tool in the corneal sampling for viral keratitis, replacing rightly or wrongly the former traditional fibers swab.
No research was specifically designed to study the corneal taking with these swabs.
Nevertheless, numerous reasons would motivate it, because of the peculiarities in ophthalmology: the corneal sampling has to be made with the slit lamp rather than in a macroscopic manner; the corneal lesion are often millimetre-length and confined; the histology of the cornea is unique and compares only imperfectly with other structures of the human body like the nasal mucosa.
In these circumstances, the properties of the stalk (rigidity, length) and of its extremity (roughness, textures, absorbance) can influence the quality of the sampling and the final result of the culture.
Study Type
Interventional
Enrollment (Actual)
146
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1S 4L8
- Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement, CHU de Québec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Slit lamp signs at the initial examination that are compatible with an Herpes simplex epithelial keratitis (Herpes simplex dendrite, herpes simplex geographic ulcer)
Exclusion Criteria:
- Topical or systemic antiviral Therapy during the last 14 days Patient with Herpes simplex stromal keratitis without epithelial involvement Herpetic lesion outside the cornea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Flocked swab (Copan 519CS01)
Sampling of the cornea by the flocked swab
|
Slit lamp corneal sampling with a Swab
|
|
Experimental: Traditionnal fiber swab (Copan 164KS01)
Sampling of the cornea by the traditional finer swab
|
Slit lamp corneal sampling with a Swab
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Result of the culture
Time Frame: 1 month after the initial visit
|
The result can be Positive or negative for Herpes simplex virus (HSV).
Even if the result will be available in less than 1 week by the clinician after the culture, the research team will collect the data 1 month in average after the initial visit.
|
1 month after the initial visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time before positivity of the culture
Time Frame: 1 month after the initial visit
|
If the culture is positive for Herpes simplex virus, what is the time lapse(in day) before the culture became positive.
The research team will collect the data 1 month in average after the initial visit by examining the microbiologic data of the laboratory.
|
1 month after the initial visit
|
|
Viral load concentration
Time Frame: 1 month after the initial visit
|
Quantitative polymerase chain reaction (PCR) will be on a part of the sampling 1 month after the initial visit.
The result will be the concentration of virus in number/ml detected in the sampling
|
1 month after the initial visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patricia-Ann Laughrea, MD, CRMC(C), Centre de recherche du CHU de Québec; Université Laval
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
January 21, 2014
First Submitted That Met QC Criteria
January 23, 2014
First Posted (Estimate)
January 24, 2014
Study Record Updates
Last Update Posted (Estimate)
February 26, 2016
Last Update Submitted That Met QC Criteria
February 25, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DR-002-1399, 2012-1649
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Herpes Simplex Keratitis
-
Second Affiliated Hospital, School of Medicine,...RecruitingCorneal Neovascularization | Herpes Simplex KeratitisChina
-
Oregon Health and Science UniversityTissue Tech Inc.WithdrawnHerpes Simplex Dendritic KeratitisUnited States
-
Chunxiao WangUnknownHerpes Simplex KeratitisChina
-
University of UlsterBedford Hospital NHS Trust; Midlands Eye Clinic; Royal Victoria Hospital, BelfastCompletedHerpes Simplex KeratitisUnited Kingdom
-
NYU Langone HealthWithdrawnHerpes Simplex Virus KeratitisUnited States
-
National Eye Institute (NEI)CompletedHerpes Simplex | Keratitis, Herpetic | Ocular Herpes SimplexUnited States
-
Shanghai BDgene Co., Ltd.RecruitingHerpes Simplex Virus Type I Stromal KeratitisChina
-
Shanghai BDgene Co., Ltd.Active, not recruitingHerpes Simplex Virus Type I Stromal KeratitisChina
-
National Eye Institute (NEI)UnknownKeratitis, Herpetic | Ocular Herpes Simplex
-
Shanghai BDgene Co., Ltd.Eye & ENT Hospital of Fudan UniversityCompletedCornea | Herpes Simplex Virus Infection | Viral Keratitis | Blindness EyeChina
Clinical Trials on Corneal sampling
-
Fondation Ophtalmologique Adolphe de RothschildWithdrawn
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Prim. Prof. Dr. Oliver Findl, MBACompleted
-
Centre hospitalier de l'Université de Montréal...AllerganCompletedGlaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma Eye | Glaucoma SecondaryCanada
-
CooperVision International Limited (CVIL)Completed
-
Stanford UniversityTerminatedNeurotrophic Keratitis | Neurotrophic Corneal Ulcer | Cranial Nerve V DiseasesUnited States
-
Iran University of Medical SciencesCompletedReduced Corneal SensationIran, Islamic Republic of
-
Fayoum UniversitySara TawfikCompletedThe Reliability of Corneal Topographic Measurements of Keratoconus EyesEgypt
-
Ulucanlar Eye Training and Research HospitalCompletedAcute Primary Angle-closure GlaucomaTurkey
-
Klinikum Chemnitz gGmbHGerman Research Foundation; KKS NetzwerkUnknownPseudophakic Bullous Keratopathy | Fuch's Endothelial DystrophyGermany